Lunit CEO Brandon Suh Lunit Inc., a South Korean cancer diagnostics AI company, will accelerate its inroads into developing markets grappling with inadequate cancer diagnostic technology and infrastructure, said its chief on Monday. “Our goal is to use AI to promote early diagnosis of bre
Teri Thomas, chief executive of Volpara Health (left), Brandon Suh, CEO of Lunit Lunit Inc., a South Korean cancer diagnostics AI company, has completed the acquisition of Volpara Health Technologies Ltd., a New Zealand-based AI software developer for breast cancer detection, for 264.7 bi
South Korean medical AI company Lunit announced on Thursday that it partnered with the Danish musculoskeletal AI diagnostics company Radiobotics ApS to enter the Europe, Middle East, and Africa (EMEA) markets. Under the agreement, the company will distribute Radiobotics' fracture and trau
South Korean medical AI company Lunit announced on Thursday that it received the first approval from the High Court of New Zealand for its plan to acquire New Zealand-based AI breast cancer diagnostics solutions company Volpara Health Technologies.According to Lunit, the acquisition approval p
Lunit Insight CXR South Korean medical AI company Lunit has secured a significant partnership with tech giant Samsung Electronics Co., signing a three-year, $1.86 million contract to supply two of its cutting-edge AI solutions. This deal represents a substantial 17.7% of Lunit's 2022 revenue, s